CARDINAL HEALTHCARE: Drug Recall
Recall #D-0173-2024 · 01/26/2022
Class II: Risk
Recall Details
- Recall Number
- D-0173-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- CARDINAL HEALTHCARE
- Status
- Terminated
- Date Initiated
- 01/26/2022
- Location
- Dublin, OH, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 unit
Reason for Recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Product Description
CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 0378-6232-01
Distribution Pattern
Nationwide USA
Other Recalls by CARDINAL HEALTHCARE
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.